
Optical methods to determine the structure of collagen fibers have garnered increasing attention for the development of non-invasive biomarkers to monitor the development and progression of several types of epithelial cancers. However, researchers at the University of Rochester in New York have found significant differences in collagen features between Black and White cancer patients, highlighting the importance of patient diversity in research on prognostic biomarkers.
“Unfortunately, there is tremendous underrepresentation of minorities in research cohorts, sometimes bringing the generalizability of trial results into question,” write the researchers, led by Edward B. Brown, PhD, associate professor at the University of Rochester Medical Center, in the journal Biophotonics Discovery.
Previous work at the Brown lab had shown the potential of a technique known as second-harmonic generation (SHG) to determine the likelihood of metastasis in patients with estrogen-receptor positive (ER+) invasive ductal carcinoma (IDC) breast cancer and patients with stage I colorectal adenocarcinoma (CRC). The SHG technique can be used to non-invasively quantify the internal structure and organization of collagen fibers by analyzing the scattering of photons in a tumor sample.
In the current study, the researchers analyzed samples from 88 patients diagnosed with stage I CRC and 243 patients with ER+ IDC. Results showed significant differences in the ratio of light scattered forward and backward by the collagen fibers, known as the F/B ratio, between Black and White patients. In breast cancer patients, the F/B ratio in the tumor-stroma interface was lower in Black patients, which is correlated with a higher metastasis risk. In colon cancer patients, the F/B ratio in the tumor tissue was higher in Black patients, which is linked to more aggressive tumor behavior in this form of cancer.
In contrast, measurements of the fiber angle variability (FAV), a prognostic indicator of survival in breast cancer patients that looks at the overall variability in the orientation of collagen fibers, showed no significant differences between Black and White patients.
These findings raise further questions about whether biological differences in collagen fibers can affect cancer progression and inform the development of more accurate diagnostic markers of metastasis. Black patients with breast or colon cancer have been reported to experience poorer outcomes than White patients, and the results suggest differences in collagen structure could partly explain the disparity seen between these demographic groups.
Future work at the Brown lab will look at whether racial differences in the F/B ratio impact the prognostic power of this biomarker based on the patient’s race. If that’s the case, recruiting a diverse enough patient cohort will be essential in future studies to develop a prognostic test that equally serves all demographics.
“For these tools to become clinically useful in predicting metastatic outcomes for patients, the next step would be to perform a multi-center trial where primary tumor excisions are imaged, F/B and FAV are determined, and follow-up data are secured and compared with these metrics,” write the researchers. “Training and validation subsets would then be used to derive and test a prognostic algorithm. Because minority groups are typically underrepresented in research cohorts, this multi-center trial must be designed carefully to cater to all ethnicities.”





